Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anticollagen type II antibodies are associated with an acute onset rheumatoid arthritis phenotype and prognosticate lower degree of inflammation during 5 years follow-up.
Manivel VA, Mullazehi M, Padyukov L, Westerlind H, Klareskog L, Alfredsson L, Saevarsdottir S, Rönnelid J. Manivel VA, et al. Among authors: mullazehi m. Ann Rheum Dis. 2017 Sep;76(9):1529-1536. doi: 10.1136/annrheumdis-2016-210873. Epub 2017 Mar 23. Ann Rheum Dis. 2017. PMID: 28336519 Free PMC article.
High anti-collagen type-II antibody levels and induction of proinflammatory cytokines by anti-collagen antibody-containing immune complexes in vitro characterise a distinct rheumatoid arthritis phenotype associated with acute inflammation at the time of disease onset.
Mullazehi M, Mathsson L, Lampa J, Rönnelid J. Mullazehi M, et al. Ann Rheum Dis. 2007 Apr;66(4):537-41. doi: 10.1136/ard.2006.064782. Epub 2006 Oct 13. Ann Rheum Dis. 2007. PMID: 17040962 Free PMC article.
Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden.
Ärlestig L, Mullazehi M, Kokkonen H, Rocklöv J, Rönnelid J, Dahlqvist SR. Ärlestig L, et al. Among authors: mullazehi m. Ann Rheum Dis. 2012 Jun;71(6):825-9. doi: 10.1136/annrheumdis-2011-200668. Epub 2011 Nov 29. Ann Rheum Dis. 2012. PMID: 22128080 Free PMC article.
Occupational physical workload and development of anti-collagen type II antibodies in rheumatoid arthritis: results from the Swedish EIRA population-based case-control study.
Zeng P, Pertsinidou E, Brynedal B, Manivel VA, Klareskog L, Mullazehi M, Saevarsdottir S, Bengtsson C, Alfredsson L, Rönnelid J. Zeng P, et al. Among authors: mullazehi m. Clin Exp Rheumatol. 2020 Sep-Oct;38(5):1029-1030. Epub 2020 Apr 3. Clin Exp Rheumatol. 2020. PMID: 32242799 Free article. No abstract available.
Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
Mathsson L, Mullazehi M, Wick MC, Sjöberg O, van Vollenhoven R, Klareskog L, Rönnelid J. Mathsson L, et al. Among authors: mullazehi m. Arthritis Rheum. 2008 Jan;58(1):36-45. doi: 10.1002/art.23188. Arthritis Rheum. 2008. PMID: 18163519 Free article.
12 results